Thayakaran, Rasiah
Goel, Ruchika
Adderley, Nicola J.
Chandan, Joht Singh
Zemedikun, Dawit
Nirantharakumar, Krishnarajah
Harper, Lorraine
Funding for this research was provided by:
Vifor Pharma
Article History
Received: 23 November 2021
Accepted: 26 July 2022
First Online: 19 August 2022
Declarations
:
: The use of IMRD is approved by the UK Research Ethics Committee (reference number: 18/LO/0441); in accordance with this approval, the study protocol was reviewed and approved by an independent Scientific Review Committee (SRC) (reference number: 20SRC064). IMRD incorporates data from The Health Improvement Network (THIN), a Cegedim database. Reference made to THIN is intended to be descriptive of the data asset licensed by IQVIA. This work used de-identified data provided by patients as a part of their routine primary care.
: Not applicable.
: RG’s work was supported by an ICMR-DHR Long-Term International Fellowship for Young Indian Biomedical Scientists (2019–2020) from the Indian Council of Medical Research. All other authors report no conflicts of interest relevant to this work.